Molecular Facets of Pluripotency

Handbook of Stem Cells

Volumn 1, Issue , 2004, Pages 27-44

  Cavaleri, Fatima ^a   Schöler, Hans ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84944405308     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012436643-5/50012-2     Document Type: Chapter

References (166)

1. Stevens L.C., Little C.C. Spontaneous testicular teratomas in an inbred strain of mice. Proc. Natl. Acad. Sci. USA 1954, 40:1080-1087.
2. Brinster R.L. The effect of cells transferred into the mouse blastocyst on subsequent development. J. Exp. Med. 1974, 140:1049-1056.
3. Mintz B., Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA 1975, 72:3585-3589.
4. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
5. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 1981, 78:7634-7638.
6. Bradley A., Evans M., Kaufman M.H., Robertson E. Formation of germ line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 1984, 309:255-256.
7. Robertson E., Bradley A., Kuehn M., Evans M. Germ line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 1986, 323:445-458.
8. Gossler A., Doetschman T., Korn R., Serfling E., Kemler R. Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc. Natl. Acad. Sci. USA 1986, 83:9065-9069.
9. Doetschman T., Gregg R.G., Maeda N., Hooper M.L., Melton D.W., Thompson S., Smithies O. Targeted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 1987, 330:576-578.
10. Thomas K.R., Capecchi M.R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987, 51:503-512.
11. Matsui Y., Zsebo K., Hogan B.L. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 1992, 70:841-847.
12. Labosky P.A., Barlow D.P., Hogan B.L. Mouse embryonic germ (EG) cell lines: transmission through the germ line and differences in the methylation imprint of insulin-like growth factor 2 receptor (Igf2r) gene compared with embryonic stem (ES) cell lines. Development 1994, 120:3197-3204.
13. Labosky P.A., Barlow D.P., Hogan B.L. Embryonic germ cell lines and their derivation from mouse primordial germ cells. Ciba Foundation Symposium 1994, 182:157-168. discussion 168-178.
14. Stewart C.L., Gadi I., Bhatt H. Stem cells from primordial germ cells can reenter the germ line. Dev. Biol. 1994, 161:626-628.
15. Till J., McCulloch E. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 1961, 14:1419-1430.
16. Smith A.G., Hooper M.L. Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev. Biol. 1987, 121:1-9.
17. Smith A.G., Heath J.K., Donaldson D.D., Wong G.G., Moreau J., Stahl M., Rogers D. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988, 336:688-690.
18. Smith A.G., Nichols J., Robertson M., Rathjen P.D. Differentiation inhibiting activity (DIA/LIF) and mouse development. Dev. Biol. 1992, 151:339-351.
19. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 1997, 15:797-819.
20. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., Kohler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994, 368:339-342.
21. Stewart C.L., Kaspar P., Brunet L.J., Bhatt H., Gadi I., Kontgen F., Abbondanzo S.J. Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 1992, 359:76-79.
22. Masu Y., Wolf E., Holtmann B., Sendtner M., Brem G., Theonen H. Disruption of the CNTF gene results in motor neuron degeneration. Nature 1993, 365:27-32.
23. Raz R., Lee C.K., Cannizzaro L.A., d'Eustachio P., Levy D.E. Essential role of STAT3 for embryonic stem cell pluripotency. Proc. Natl. Acad. Sci. USA 1999, 96:2846-2851.
24. Scherer C.A., Chen J., Nachabeh A., Hopkins N., Ruley H.E. Transcriptional specificity of the pluripotent embryonic stem cell. Cell Grow. Diff. 1996, 7:1393-1401.
25. Ben-Shushan E., Thompson J.R., Gudas J.L., Bergman Y. Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol. Cell. Biol. 1998, 18:1866-1878.
26. Lake J., Rathjen J., Remiszewski J., Rathjen P.D. Reversible programming of pluripotent cell differentiation. J. Cell Science 2000, 113:555-566.
27. Patthy L. Homology of a domain of the growth hormone-prolactin receptor family with type III modules of fibronectin. Cell 1990, 61:13-14.
28. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 1990, 87:6934-6938.
29. Bazan J.F. WKS motifs and the cytokine receptor framework of tissue factor [comment]. Trends Biochem. Sci. 1991, 16:329.
30. Nichols J., Davidson D., Taga T., Yoshida K., Chambers I., Smith A. Complementary tissue-specific expression of LIF and LIF-receptor mRNAs in early mouse embryogenesis. Mech. Dev. 1996, 57:123-131.
31. Yoshida K., Chambers I., Nichols J., Smith A., Saito M., Yasukawa K., Shoyab M., Taga T., Kishimoto T. Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signaling pathways. Mech. Dev. 1994, 45:163-171.
32. Conover J.C., Ip N.Y., Poueymirou W.T., Bates B., Goldfarb M.P., DeChiara T.M., Yancopoulos G.D. Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells. Development 1993, 119:559-565.
33. Wolf E., Kramer R., Polejaeva I., Thoenen H., Brem G. Efficient generation of chimeric mice using embryonic stem cells after long-term culture in the presence of ciliary neurotrophic factor. Transgen. Res. 1994, 3:152-158.
34. Nichols J., Chambers I., Smith A. Derivation of germ line competent embryonic stem cells with a combination of interleukin-6 and soluble interleukin-6 receptor. Exp. Cell Res. 1994, 215:237-239.
35. Li M., Sendtner M., Smith A. Essential function of LIF receptor in motor neurons. Nature 1995, 378:724-727.
36. Ware C.B., Horowitz M.C., Renshaw B.R., Hunt J.S., Liggitt D., Koblar S.A., Gliniak B.C., McKenna H.J., Papayannopoulou T., Thoma B. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural, and metabolic defects and results in perinatal death. Development 1995, 121:1283-1299.
37. Nakashima K., Wiese S., Yanagisawa M., Arakawa H., Kimura N., Hisatsune T., Yoshida K., Kishimoto T., Sendtner M., Taga T. Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation. J. Neurosci. 1999, 19:5429-5434.
38. Yoshida K., Taga T., Saito M., Suematsu S., Kumanogoh A., Tanaka T., Fujiwara H., Hirata M., Yamagami T., Nakahata T., Hirabayashi T., Yoneda Y., Tanaka K., Wang W.Z., Mori C., Shiota K., Yoshida N., Kishimoto T. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA 1996, 93:407-411.
39. DeChiara T.M., Vejsada R., Poueymirou W.T., Acheson A., Suri C., Conover J.C., Friedman B., McClain J., Pan L., Stahl N. Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 1995, 83:313-322.
40. Niwa H., Burdon T., Chambers I., Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 1998, 12:2048-2060.
41. Nichols J., Chambers I., Taga T., Smith A. Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development 2001, 128:2333-2339.
42. Fukada T., Hibi M., Yamanaka Y., Takahashi-Tezuka M., Fujitani Y., Yamaguchi T., Nakajima K., Hirano T. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in antiapoptosis. Immunity 1996, 5:449-460.
43. Hirano T., Ishihara K., Hibi M. Roles of STAT3 in mediating the cell growth, differentiation, and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000, 19:2548-2556.
44. Murakami M., Narazaki M., Hibi M., Yawata H., Yasukawa K., Hamaguchi M., Taga T., Kishimoto T. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc. Natl. Acad. Sci. USA 1991, 88:11,349-11,353.
45. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
46. Lutticken C., Wegenka U.M., Yuan J., Buschmann J., Schinlder C., Ziemiecki A., Harpur A.G., Wilks A.F., Yasukawa K., Taga T. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 1994, 263:89-92.
47. Matsuda T., Yamanaka Y., Hirano T. Interleukin-6-induced tyrosine phosphorylation of multiple proteins in murine hematopoietic lineage cells. Biochem. Biophys. Res. Comm. 1994, 200:821-828.
48. Stahl N., Boulton T.G., Farruggella T., Ip N.Y., Davis S., Witthuhn B.A., Quelle F.W., Silvennoinen O., Barbeiri G., Pellegrini S. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6β receptor components. Science 1994, 263:92-95.
49. Heinrich P.C., Behrmann I., Muller-Newen G., Schaper F., Graeve L. Interleukin-6-type cytokine signaling through the gp130/Jak/STAT pathway. Biochem. J. 1998, 334:297-314. (Pt. 2).
50. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 2000, 351:289-305. (Pt. 2).
51. Vanhaesebroeck B., Alessi D.R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 2000, 346:561-576. (Pt. 3).
52. Zhong Z., Wen Z., Darnell J.E. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994, 264:95-98.
53. Cao X., Tay A., Guy G.R., Tan Y.H. Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol. Cell. Biol. 1996, 16:1595-1603.
54. Wen Z., Zhong Z., Darnell J.E. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995, 82:241-250. (1995).
55. Chung J., Uchida E., Grammer T.C., Blenis J. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell. Biol. 1997, 17:6508-6516.
56. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T., Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 1997, 94:3801-3804.
57. Hocke G.M., Cui M.Z., Fey G.H. The LIF response element of the α2 macroglobulin gene confers LIF-induced transcriptional activation in embryonal stem cells. Cytokine 1995, 7:491-502.
58. Boeuf H., Hauss C., Graeve F.D., Baran N., Kedinger C. Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells. J. Cell Biol. 1997, 138:1207-1217.
59. Matsuda T., Nakamura T., Nakao K., Arai T., Katsuki M., Heike T., Yokota T. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 1999, 18:4261-4269.
60. Stahl N., Farruggella T.J., Boulton T.G., Zhong Z., Darnell J.E., Yancopoulos G.D. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 1995, 267:1349-1353.
61. Dani C., Chambers I., Johnstone S., Robertson M., Ebrahimi B., Saito M., Taga T., Li M., Burdon T., Nichols J., Smith A. Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway. Dev. Biol. 1998, 203:149-162.
62. Rathjen P.D., Nichols J., Toth S., Edwards D.R., Heath J.K., Smith A.G. Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations. Genes Dev. 1990, 4:2308-2318.
63. Burdon T., Chambers I., Stracey C., Niwa H., Smith A. Signaling mechanisms regulating self-renewal and differentiation of pluripotent embryonic stem cells. Cells Tissues Organs 1999, 165:131-143.
64. Hof P., Pluskey S., Dhe-Paganon S., Eck M.J., Shoelson S.E. Crystal structure of the tyrosine phosphatase SHP-2. Cell 1998, 92:441-450.
65. Qu C.K., Feng G.S. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation. Oncogene 1998, 17:433-439.
66. Peyssonnaux C., Eychene A. The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell 2001, 93:53-62.
67. Takahashi-Tezuka M., Yoshida Y., Fukada T., Ohtani T., Yamanaka Y., Nishida K., Nakajima K., Hibi M., Hirano T. Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Mol. Cell. Biol. 1998, 18:4109-4117.
68. Feng S., Chen J.K., Yu H., Simon J.A., Schreiber S.L. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 1994, 266:1241-1247.
69. Cheng A.M., Saxton T.M., Sakai R., Kulkarni S., Mbamalu G., Vogel W., Tortorice C.G., Cardiff R.D., Cross J.C., Muller W.J., Pawson T. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell 1998, 95:793-803.
70. Scholer H.R. Octamania: The POU factors in murine development. Trends Genet. 1991, 7:323-329.
71. Brehm A., Ohbo K., Zwerschke W., Botquin V., Jansen-Durr P., Scholer H.R. Synergism with germ line transcription factor Oct-4: viral oncoproteins share the ability to mimic a stem cell-specific activity. Mol. Cell. Biol. 1999, 19:2635-2643.
72. Remenyi A., Tomilin A., Pohl E., Lins K., Philippsen A., Reinbold R., Scholer H.R., Wilmanns M. Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. Mol. Cell 2001, 8:569-580.
73. Herr W., Cleary M.A. The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev. 1995, 9:1679-1693.
74. Brehm A., Ohbo K., Scholer H. The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain. Mol. Cell. Biol. 1997, 17:154-162.
75. Verrijzer C.P., van Oosterhout J.A., van Weperen W.W., van der Vliet P.C. POU proteins bend DNA via the POU-specific domain. EMBO J. 1991, 10:3007-3014.
76. Botfield M.C., Jancso A., Weiss M.A. Biochemical characterization of the Oct-2 POU domain with implications for bipartite DNA recognition. Biochemistry 1992, 31:5841-5848.
77. Verrijzer C.P., Alkema M.J., van Weperen W.W., Van Leeuwen H.C., Strating M.J., van der Vliet P.C. The DNA binding specificity of the bipartite POU domain and its subdomains. EMBO J. 1992, 11:4993-5003.
78. Pomerantz J.L., Sharp P.A. Homeodomain determinants of major groove recognition. Biochemistry 1994, 33:10,851-10,858.
79. Klemm J.D., Rould M.A., Aurora R., Herr W., Pabo C.O. Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 1994, 77:21-32.
80. Vigano M.A., Staudt L.M. Transcriptional activation by Oct-3: Evidence for a specific role of the POU-specific domain in mediating functional interaction with Oct-1). Nucleic Acids Res. 1996, 24:2112-2118.
81. Okamoto K., Okazawa H., Okuda A., Sakai M., Muramatsu M., Hamada H. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 1990, 60:461-472.
82. Scholer H.R., Ruppert S., Suzuki N., Chowdhury K., Gruss P. New type of POU domain in germ line-specific protein Oct-4. Nature 1990, 344:435-439.
83. Scholer H.R., Ciesiolka T., Gruss P. A nexus between Oct-4 and E1A: Implications for gene regulation in embryonic stem cells. Cell 1991, 66:291-304.
84. Imagawa M., Miyamoto A., Shirakawa M., Hamada H., Muramatsu M. Stringent integrity requirements for both transactivation and DNA-binding in a transactivator, Oct3. Nucleic Acids Res. 1991, 19:4503-4508.
85. Palmieri S.L., Peter W., Hess H., Scholer H.R. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev. Biol. 1994, 166:259-267.
86. Yeom Y.I., Ha H.S., Balling R., Scholer H.R., Artzt K. Structure, expression, and chromosomal location of the Oct-4 gene. Mech. Dev. 1991, 35:171-179.
87. Rosner M.H., Vigano M.A., Ozato K., Timmons P.M., Poirier F., Rigby P.W., Staudt L.M. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 1990, 345:686-692.
88. Scholer H.R., Dressler G.R., Balling R., Rohdewohld H., Gruss P. Oct-4: A germ line-specific transcription factor mapping to the mouse t-complex. EMBO J. 1990, 9:2185-2195.
89. Yeom Y.I., Fuhrmann G., Ovitt C.E., Brehm A., Ohbo K., Gross M. Germ line regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 1996, 122:881-894.
90. Scholer H.R., Balling R., Hatzopoulos A.K., Suzuki N., Gruss P. Octamer-binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J. 1989, 8:2551-2557.
91. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A., Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow [comment]. Nature 2002, 418:41-49.
92. Jin T., Branch D.R., Zhang X., Qi S., Youngson B., Goss P.E. Examination of POU homeobox gene expression in human breast cancer cells. Int. J. Cancer 1999, 81:104-112.
93. Hansis C., Grifo J.A., Krey L.C. Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol. Human Reprod. 2000, 6:999-1004.
94. Pera M.F., Cooper S., Mills J., Parrington J.M. Isolation and characterization of a multipotent clone of human embryonal carcinoma cells. Differentiation 1989, 42:10-23.
95. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro [comment]. Nat. Biotechnol. 2000, 18:399-404. [Erratum appears in Nat. Biotechnol. (2000). 18, 559].
96. Shamblott M.J., Axelman J., Wang S., Bugg E.M., Littlefield J.W., Donovan P.J., Blumenthal P.D., Huggins G.R., Gearhart J.D. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. USA 1998, 95:13,726-13,731. [Erratum appears in Proc. Nat. Acad. Sci. USA (1999). 96, 1162].
97. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nenenius D., Chambers I., Scholer H.R., Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998, 95:379-391.
98. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation, or self-renewal of ES cells [comment]. Nat. Genet. 2000, 24:372-376.
99. Mountford P., Zevnik B., Duwel A., Nichols J., Li M., Dani C., Robertson M., Chambers I., Smith A. Dicistronic targeting constructs: Reporters and modifiers of mammalian gene expression. Proc. Natl. Acad. Sci. USA 1994, 91:4303-4307.
100. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 1992, 89:5547-5551.
101. Niwa H., Masui S., Chambers I., Smith A.G., Miyazaki J. Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. Mol. Cell. Biol. 2002, 22:1526-1536.
102. Okazawa H., Okamoto K., Ishino F., Ishino-Kaneko T., Takeda S., Toyoda Y., Muramatsu M., Hamada H. The oct3 gene, a gene for an embryonic transcription factor, is controlled by a retinoic acid repressible enhancer. EMBO J. 1991, 10:2997-3005.
103. Minucci S., Botquin V., Yeom Y.I., Dey A., Sylvester I., Zand D.J., Ohbo K., Ozato K., Scholer H.R. Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo. EMBO J. 1996, 15:888-899.
104. Pikarsky E., Sharir H., Ben-Shushan E., Bergman Y. Retinoic acid represses Oct-3/4 gene expression through several retinoic acid-responsive elements located in the promoter-enhancer region. Mol. Cell. Biol. 1994, 14:1026-1038.
105. Schoorlemmer J., van Puijenbroeck A., van Den Eijnden M., Jonk L., Pals C., Kruijer W. Characterization of a negative retinoic acid response element in the murine Oct4 promoter. Mol. Cell. Biol. 1994, 14:1122-1136.
106. Sylvester I., Scholer H.R. Regulation of the Oct-4 gene by nuclear receptors. Nucleic Acids Res. 1994, 22:901-911.
107. Ben-Shushan E., Sharir H., Pikarsky E., Bergman Y. A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor-retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells. Mol. Cell. Biol. 1995, 15:1034-1048.
108. Fuhrmann G., Sylvester I., Scholer H.R. Repression of Oct-4 during embryonic cell differentiation correlates with the appearance of TRIF, a transiently induced DNA-binding factor. Cell. Mol. Biol. 1999, 45:717-724.
109. Fuhrmann G., Chung A.C., Jackson K.J., Hummelke G., Baniahmad A., Sutter J., Sylvester I., Scholer H.R., Cooney A. Mouse germ line restriction of Oct4 expression by germ cell nuclear factor. Dev. Cell 2001, 1:377-387.
110. Barnea E., Bergman Y. Synergy of SF1 and RAR in activation of Oct-3/4 promoter. J. Biol. Chem. 2000, 275:6608-6619.
111. Chung A.C., Katz D., Pereira F.A., Jackson K.J., DeMayo F.J., Cooney A.J., O'Malley B.W. Loss of orphan receptor germ cell nuclear factor function results in ectopic development of the tail bud and a novel posterior truncation. Mol. Cell. Biol. 2001, 21:663-677.
112. Lan Z.J., Chung A.C., Xu X., DeMayo F.J., Cooney A.J. The embryonic function of germ cell nuclear factor is dependent on the DNA binding domain. J. Biol. Chem. 2002, 277:50,660-50,667.
113. Jaenisch R. DNA methylation and imprinting: why bother? [comment]. Trends Genet. 1997, 13:323-329.
114. Kafri T., Ariel M., Brandeis M., Shemer R., Urven L., McCarrey J., Cedar H., Razin A. Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line. Genes Dev. 1992, 6:705-714.
115. Brandeis M., Frank D., Keshet I., Siegfried Z., Mendelsohn M., Nemes A., Temper V., Razin A., Cedar H. Sp1 elements protect a CpG island from de novo methylation. Nature 1994, 371:435-438.
116. Macleod D., Charlton J., Mullins J., Bird A.P. Sp1 sites in the mouse Aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 1994, 8(19):2282-2292.
117. Gidekel S., Bergman Y. A unique developmental pattern of Oct-3/4 DNA methylation is controlled by a cis-demodification element. J. Biol. Chem. 2002, 277:34,521-34,530.
118. Hay D.L., Lopata A. Chorionic gonadotropin secretion by human embryos in vitro. J. Clin. Endocrin. Met. 1988, 67:1322-1324.
119. Dokras A., Sargent I.L., Ross C., Gardner R.L., Barlow D.H. The human blastocyst: morphology and human chorionic gonadotrophin secretion in vitro. Human Reprod. 1991, 6:1143-1151.
120. Seshagiri P.B., Hearn J.P. In vitro development of in vivo-produced rhesus monkey morulae and blastocysts to hatched, attached, and postattached blastocyst stages: Morphology and early secretion of chorionic gonadotrophin. Human Reprod. 1993, 8:279-287.
121. Liu L., Roberts R.M. Silencing of the gene for the beta subunit of human chorionic gonadotropin by the embryonic transcription factor Oct-3/4. J. Biol. Chem. 1996, 271:16,683-16,689.
122. Liu L., Leaman D., Villalta M., Roberts R.M. Silencing of the gene for the alpha-subunit of human chorionic gonadotropin by the embryonic transcription factor Oct-3/4. Mol. Endocrin. 1997, 11:1651-1658.
123. Ezashi T., Ghosh D., Roberts R.M. Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4. Mol. Cell. Biol. 2001, 21:7883-7891.
124. Ezashi T., Ealy A.D., Ostrowski M.C., Roberts R.M. Control of interferon-tau gene expression by Ets-2. Proc. Nat. Acad. Sci. USA 1998, 95:7882-7887.
125. Rogers M.B., Hosler B.A., Gudas L.J. Specific expression of a retinoic acid-regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast, and spermatocytes. Development 1991, 113:815-824.
126. Hosler B.A., LaRosa G.J., Grippo J.F., Gudas L.J. Expression of REX-1, a gene containing zinc-finger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells. Mol. Cell. Biol. 1989, 9:5623-5629.
127. Kraft H.J., Mosselman S., Smits H.A., Hohenstein P., Piek E., Chen Q., Artzt K., van Zoelen E.J. Oct-4 regulates alternative platelet-derived growth factor α receptor gene promoter in human embryonal carcinoma cells. J. Biol. Chem. 1996, 271:12,873-12,878.
128. Yuan H., Corbi N., Basilico C., Dailey L. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 1995, 9:2635-2645.
129. Ambrosetti D.C., Scholer H.R., Dailey L., Basilico C. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. J. Biol. Chem. 2000, 275:23,387-23,397.
130. Nishimoto M., Fukushima A., Okuda A., Muramatsu M. The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol. Cell. Biol. 1999, 19:5453-5465.
131. Avilion A.A., Nicolis S.K., Pevny L.H., Perez L., Vivian N., Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 2003, 17:126-140.
132. Fraidenraich D., Lang R., Basilico C. Distinct regulatory elements govern Fgf4 gene expression in the mouse blastocyst, myotomes, and developing limb. Dev. Biol. 1998, 204:197-209.
133. Ambrosetti D.C., Basilico C., Dailey L. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol. Cell. Biol. 1997, 17:6321-6329.
134. Dailey L., Basilico C. Coevolution of HMG domains and homeodomains and the generation of transcriptional regulation by Sox/POU complexes. J. Cell. Phys. 2001, 186:315-328.
135. Nowling T.K., Johnson L.R., Wiebe M.S., Rizzino A. Identification of the transactivation domain of the transcription factor Sox-2 and an associated coactivator. J. Biol. Chem. 2000, 275:3810-3818.
136. Brookes S., Smith R., Thurlow J., Dickson C., Peters G. The mouse homologue of hst/k-FGF: Sequence, genome organization, and location relative to int-2. Nucleic Acids Res. 1989, 17:4037-4045.
137. Taira M., Yoshida T., Miyagawa K., Sakamoto H., Terada M., Sugimura T. cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. Proc. Natl. Acad. Sci. USA 1987, 84:2980-2984.
138. Yoshida T., Miyagawa K., Odagiri H., Sakamoto H., Little P.F., Terada M., Sugimura T. Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein. Proc. Natl. Acad. Sci. USA 1987, 84:7305-7309. [Erratum appears in Proc. Nat. Acad. Sci. USA (1988). 85, 1967].
139. Okuda A., Fukushima A., Nishimoto M., Orimo A., Yamagishi T., Nabeshima Y., Kuro-o M., Boon K., Keaveney M., Stunnenberg H.G., Muramatsu M. UTF1, a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extraembryonic cells. EMBO J. 1998, 17:2019-2032.
140. Tomioka M., Nishimoto M., Miyagi S., Katayanagi T., Fukui N., Niwa H., Muramatsu M., Okuda A. Identification of Sox-2 regulatory region, which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res. 2002, 30:3202-3213.
141. Tokuzawa Y., Kaiho E., Maruyama M., Takahashi K., Mitsui K., Maeda M., Niwa H., Yamanaka S. Fbx15 is a novel target of Oct4/3 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol. Cell. Biol. 2003, 23:2699-2708.
142. Botquin V., Hess H., Fuhrmann G., Anastassiadis C., Gross M.K., Vriend G., Scholer H.R. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev. 1998, 12:2073-2090.
143. D.T. Denhardt, W.T. Butler, A.F. Chambers, D.R. Senger (Eds.). Osteopontin: Role in cell signaling and adhesion. Annals of the New York Academy of Sciences 1995, Vol. 760. New York Academy of Sciences, New York.
144. Tomilin A., Remenyi A., Lins K., Bak H., Leidel S., Vriend G., Wilmanns M., Scholer H.R. Synergism with the coactivator OBF-1 (OCA-B, BOB-1) is mediated by a specific POU dimer configuration. Cell 2000, 103:853-864.
145. Kapiloff M.S., Farkash Y., Wegner M., Rosenfeld M.G. Variable effects of phosphorylation of Pit-1 dictated by the DNA response elements. Science 1991, 253:786-789.
146. Segil N., Roberts S.B., Heintz N. Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA-binding activity. Science 1991, 254:1814-1816.
147. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113:643-655.
148. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113:631-642.
149. Labosky P.A., Kaestner K.H. The winged-helix transcription factor Hfh2 is expressed in neural crest and spinal cord during mouse development. Mech. Dev. 1998, 76:185-190.
150. Hromas R., Ye H., Spinella M., Dmitrovsky E., Xu D., Costa R. Genesis, a winged-helix transcriptional repressor, has embryonic expression limited to the neural crest and stimulates proliferation in vitro in a neural development model. Cell Tissue Res. 1999, 297:371-382.
151. Dottori M., Gross M.K., Labosky P., Goulding M. The winged-helix transcription factor Foxd3 suppresses interneuron differentiation and promotes neural crest cell fate. Development 2001, 128:4127-4138.
152. Hanna L.A., Foreman R.K., Tarasenko I.A., Kessler D.S., Labosky P.A. Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo. Genes Dev. 2002, 16:2650-2661.
153. Guo Y., Costa R., Ramsey H., Starnes T., Vance G., Robertson K., Kelley M., Reinbold R., Scholer H., Hromas R. The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression. Proc. Natl. Acad. Sci. USA 2002, 99:3663-3667.
154. Rappolee D.A., Basilico C., Patel Y., Werb Z. Expression and function of FGF-4 in peri-implantation development in mouse embryos. Development 1994, 120:2259-2269.
155. Wilder P.J., Kelly D., Brigman K., Peterson C.L., Nowling T., Gao Q.S., McComb R.D., Capecchi M.R., Rizzino A. Inactivation of the FGF-4 gene in embryonic stem cells alters the growth and/or the survival of their early differentiated progeny. Dev. Biol. 1997, 192:614-629.
156. Tanaka S., Kunath T., Hadjantonakis A.K., Nagy A., Rossant J. Promotion of trophoblast stem cell proliferation by FGF4. Science 1998, 282:2072-2075.
157. Feldman B., Poueymirou W., Papaionnou V.E., DeChiara T.M., Goldfarb M. Requirement of FGF-4 for postimplantation mouse development. Science 1995, 267:246-249.
158. Arman E., Haffner-Krausz R., Chen Y., Heath J.K., Lonai P. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc. Natl. Acad. Sci. USA 1998, 95:5082-5087.
159. Larue L., Ohsugi M., Hirchenhain J., Kemler R. E-cadherin-null mutant embryos fail to form a trophectoderm epithelium. Proc. Natl. Acad. Sci. USA 1994, 91:8263-8267.
160. Tanaka Y., Patestos N.P., Maekawa T., Ishii S. B-myb is required for inner cell mass formation at an early stage of development. J. Biol. Chem. 1999, 274:28,067-28,070.
161. Voss A.K., Thomas T., Petrou P., Anastassiadis K., Scholer H., Gruss P. Taube nuss is a novel gene essential for the survival of pluripotent cells of early mouse embryos. Development 2000, 127:5449-5461.
162. Takai H., Naka K., Okada Y., Watanabe M., Harada N., Saito S., Anderson C.W., Appella E., Nakanashi M., Suzuki H., Nagashima K., Sawa H., Ikeda K., Motoyama N. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J. 2002, 21:5195-5205.
163. Niwa H. Molecular mechanism to maintain stem cell renewal of ES cells. Cell Struc. Func. 2001, 26:137-148.
164. La Thangue N.B., Rigby P.W. An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells. Cell 1987, 49:507-513.
165. Preston S.L., Alison M.R., Forbes S.J., Direkze N.C., Poulsom R., Wright N.A. The new stem cell biology: Something for everyone. Mol. Pathol. 2003, 56:86-96.
166. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts [comment]. Science 1998, 282:1145-1147. [Erratum appears in Science (1998). 282, 1827].